Lazard Ltd Overview
Lazard is the oldest and among the largest of the independent ("elite boutique") investment banks, and the only one at scale that pairs a global, conflict-light advisory franchise with a sizable institutional asset manager. Founded in 1848, it advises corporations, sponsors and sovereigns on M&A, restructuring and liability management, capital solutions, private capital, activism defense and geopolitics. Through Lazard Asset Management (LAM) and Lazard Frères Gestion, it manages about $284 billion, weighted toward active global, international and emerging-markets equity. CEO and Chairman Peter Orszag's "Lazard 2030" plan aims to double firm revenue from the 2023 base, raise advisory productivity to $12.5 million per MD, push the adjusted compensation ratio to 60% or below, and pivot toward private-capital connectivity. The pending $575 million Campbell Lutyens acquisition, to be housed in a new third business, Lazard CL, is the centerpiece of that pivot. The equity story in late 2026 is a tension between strategic progress and near-term margin compression: an adjusted comp ratio of 69.9% in H1 2026, two consecutive EPS misses, and shares near 52-week lows.
Company self-description (paraphrased from the FY2025 10-K and corporate boilerplate)
Lazard describes itself as the preeminent financial advisory and asset management firm, operating across North and South America, Europe, the Middle East, Asia and Australia. In advisory, it serves on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics and other strategic matters. In asset management, it provides investment solutions to institutions, corporations, governments, partnerships, family offices and high-net-worth individuals. The firm reports two operating segments, Financial Advisory and Asset Management, plus a Corporate segment that holds treasury, investment and certain financing activities.
Business model and revenue model
Lazard is a pure service business. It has no product, licensing or subscription revenue in the conventional sense. Its revenue model has three components:
-
Success-based and retainer advisory fees (about 59–60% of FY2025 revenue). M&A fees are paid mostly on completion, so revenue tracks completed rather than announced activity and lags the deal cycle by roughly two to four quarters. Non-M&A advisory includes restructuring and liability management, private capital advisory (fund placement and secondaries), capital markets advisory, and shareholder, sovereign and geopolitical advisory. These lines are partly countercyclical and partly retainer-based. Management said FY2025 advisory revenue was just under 60% M&A and slightly over 40% non-M&A (Q4 2025 earnings call commentary).
-
Recurring management fees on AUM (about 36% of FY2025 adjusted revenue). Adjusted management fees and other revenue were $1,107 million in FY2025. These fees are basis points on AUM, so they depend on market levels, FX (about 67–68% of AUM has foreign-currency exposure) and net flows.
-
Incentive fees. These are performance-based and volatile: $59 million in FY2025 (of which $37 million came in Q4), versus a record $120 million in FY2021.
Cost model. Lazard is compensation-heavy. The adjusted comp ratio was 65.5% in FY2025 and 69.9% in H1 2026. The adjusted non-comp ratio was 20.2% in FY2025. Operating leverage therefore depends almost entirely on revenue per MD and the comp ratio.
Value-chain position
In advisory, Lazard sits at the top of the value chain as an independent, balance-sheet-light adviser. It does not lend, underwrite at scale or trade principally, which it presents as freedom from conflicts. Its competitors for mandates are bulge-bracket banks, which bundle financing, and other independents. In asset management, it is an active, fundamentals-driven manager selling primarily to institutions (pensions, sovereigns, endowments), sub-advisory relationships and intermediaries, with a French private-client and wealth arm (Lazard Frères Gestion) and a growing alternatives and private-markets presence (Lazard Elaia Capital, Elaia Partners).
Customer types and end-markets
| Customer type | Segment | Notes |
|---|---|---|
| Public and private corporations | Financial Advisory | Core strategic M&A franchise; marquee 2026 roles include NextEra Energy on its combination with Dominion Energy (combined EV about $420 billion, which Lazard called the largest energy deal in history) |
| Financial sponsors (PE, infrastructure, credit funds) | FA / PCA / Lazard CL | Private-capital connectivity rose from about 25% of advisory revenue in 2019 to about 40% in 2026; target is about 50%, expected to be reached on closing of Campbell Lutyens (Q1 2026 call) |
| Governments and sovereigns | FA (Sovereign Advisory) | Debt restructurings and sovereign strategy |
| Distressed issuers and creditors | FA (RLM) | Debtor and creditor mandates |
| Institutional investors (pensions, SWFs, endowments, insurers) | Asset Management | Largest AUM channel |
| Financial intermediaries and sub-advisory | Asset Management | A large sub-advised redemption drove FY2025 net outflows; excluding it, FY2025 net inflows were $8.4 billion |
| HNW, family offices, French private clients | Asset Management (LFG, Lazard Frères Banque) | Wealth and private banking in France |
Independent characterization
Lazard is best understood as two cyclical businesses with offsetting but imperfect hedges. Advisory is geared to M&A completions and sponsor activity. Asset management is geared to equity markets, the US dollar (a weaker dollar helps) and the secular active-to-passive headwind. The 2024–2026 strategy layers on a third leg: private-capital advisory, which is more annuity-like and secular-growth-oriented. The investment debate turns less on franchise quality, which is uncontested, than on conversion. The questions are whether heavy MD hiring (2024–2026) converts to revenue fast enough to bring the comp ratio from about 70% toward 60%, and whether LAM's flow inflection (best first-half net inflows in nearly 20 years in H1 2026) proves durable given monthly outflows in May and September 2026.
Strategy
Stated strategy: "Lazard 2030" (themes paraphrased from releases, calls and the 2026 proxy)
-
Double firm-wide revenue by 2030 relative to 2023 (adjusted net revenue of about $2.44 billion in 2023, so roughly $4.9 billion by 2030).
-
Productivity: reach $12.5 million of revenue per Financial Advisory MD by 2030, from $8.9 million in FY2025. This target was added in December 2025.
-
Talent growth: net MD additions (FA exceeded its growth goal in 2025 with 28 net MD additions).
-
Cost discipline: adjusted comp ratio of 60% or below; adjusted non-comp ratio of 16–20%. Timing is explicitly dependent on market conditions.
-
Private-capital connectivity: raise the share of advisory revenue linked to private capital to about 50%, from about 40% today and about 25% in 2019. Management says the Campbell Lutyens closing achieves this.
-
Shareholder returns: management targets 10–15% annual total shareholder return (per secondary summary; verify against investor materials).
-
Asset Management repositioning: restore positive net flows. The goal was positive flows in 2026; H1 2026 net flows were +$7.4 billion. Levers include new leadership (Hogbin), private markets (Elaia), multi-asset and solutions, and simplification (Edgewater exit).
-
AI-enablement: become the leading AI-enabled independent financial firm (December 2025 announcement; Soto leads).
Initiative register (last 24 months)
| Date | Initiative | Type | Detail / target |
|---|---|---|---|
| 2024–ongoing | Lazard 2030 | Transformation program | Targets above |
| Apr 2024 | Lazard Elaia Capital | New business (AM) | Late-stage and growth tech PE vehicle with Elaia; first fund targeted for 2025 |
| 2024–2026 | Senior MD hiring wave | Talent investment | 21 MD hires in 2025; numerous 2026 hires in Media/Sports, Financial Sponsors, MedTech, Defense Tech, European Consumer, Industrials, DACH |
| Jul–Q3 2025 | Refinancing | Capital structure | 2035 notes issued; 2027 notes redeemed |
| Sep–Dec 2025 | LAM leadership reset | Management | Hogbin appointed |
| Dec 2025 | FA leadership expansion and AI agenda | Organization | McGuire and Donahue as co-heads of FA North America; Marcus Schenck to lead global banker talent development |
| Feb 2026 | Edgewater exit | Simplification | About $1.5 billion of AUM divested |
| Apr 2026 | Campbell Lutyens and Lazard CL | M&A / new business | About $575 million plus up to $85 million earn-out; about $500 million combined 2027 revenue; EPS-accretive in 2027 with no synergies assumed |
| Jun 2026 | Elaia Partners control (51%) | AM build | About $1.0 billion of AUM consolidated |
| 2,026 | Operational efficiency drive under the new CFO | Cost program | No quantified cost-saving target publicly disclosed; non-comp growth guided at mid-to-high single digits for 2026 |
| Jul 2026 | $200 million additional buyback | Capital return | Authorization runs through December (year per filing) |
Medium-term guidance and outlook statements
-
Financial advisory activity is expected to accelerate in 2026, with timing subject to fluctuation (Q4 2025 call). By Q2 2026 this was reframed: second-half revenue should exceed the first half, supported by the pipeline and ramping MD productivity.
-
Asset Management is expected to produce positive net flows in 2026 (Q4 2025 call). H1 2026 delivered +$7.4 billion, but monthly releases show net outflows of $1.4 billion in May, $0.2 billion in June and $0.9 billion in September.
-
The comp ratio should trend down significantly in 2027–2028 (Q2 2026 call).
-
The Q2 2026 tax rate was anomalous because of a catch-up from Q1 equity-vesting tax benefits, and is not indicative of the full-year rate.
Products & Services
Lazard does not disclose pricing for advisory services, which are negotiated per mandate, and publishes fund-level fees only in fund prospectuses. "Launch year" is given where publicly known.
Financial Advisory
| Offering | Description and capabilities | Target client | Pricing model | Flagship / notable recent mandates |
|---|---|---|---|---|
| M&A and Strategic Advisory | Buy-side and sell-side advice, mergers of equals, cross-border deals, defense, fairness opinions; global sector coverage groups (Healthcare, TMT, Industrials, Energy & Infrastructure, Consumer, FIG, Real Estate, and others) | Large-cap and mid-cap corporates, boards, special committees | Success fees, plus retainers and opinion fees | NextEra Energy on its combination with Dominion Energy (combined EV about $420 billion, Q2 2026); Altice France on the proposed sale of SFR to Bouygues Telecom, iliad/Free and Orange (up to €21 billion); SunOpta's $1.1 billion sale to Refresco; Labcorp's $722 million acquisition of select BioReference assets (Oct 2026); Galderma's $1.5 billion acquisition of ZO Skin Health (Oct 2026) |
| Financial Sponsors Group | Coverage of PE and infrastructure firms for portfolio M&A and exits | PE, infrastructure, credit sponsors | Success fees | Sponsor activity was the weaker part of M&A in 2026 (Q1 and Q2 2026 calls) |
| Capital Solutions / Strategic Capital Solutions (Capital Markets Advisory, Capital Structure Advisory) | Independent advice on equity and debt raises, IPOs, converts, private placements, ratings, capital structure; ECM advisory build-out (Head of ECM Advisory North America hired from Bank of America, 2026) | Corporates, sponsors | Fees per mandate | Global Head: Tim Donahue (now also co-head of FA North America) |
| Restructuring & Liability Management (RLM) | Debtor and creditor advisory, liability-management exercises, in- and out-of-court restructurings | Distressed issuers, creditor groups | Monthly retainers plus success fees | Described as a "strong year" in 2025 and "broad range of mandates" in H1 2026 |
| Private Capital Advisory (PCA) — to be folded into Lazard CL | Primary fund placement, GP-led and LP secondaries, GP capital advisory, across PE, infrastructure, private credit and real estate | GPs, LPs, sponsors | Placement fees (percentage of capital raised), secondary advisory fees | Record revenue in 2025; revenue more than doubled over five years per Holcombe Green |
| Lazard CL (pending) | Combined Lazard PCA and Campbell Lutyens: more than 280 advisory professionals, 18 offices, institutional distribution team of more than 60, more than 230 fee-paying mandates in two years, more than $190 billion raised and more than $100 billion of secondary volume over two years | Global GP and LP community | Placement and advisory fees | About $500 million estimated combined 2027 revenue (company estimate) |
| Shareholder Advisory | Activism defense, shareholder engagement, proxy contests | Public company boards | Retainers plus event fees | Publishes semi-annual "Review of Shareholder Activism" (H1 2026 edition) |
| Sovereign Advisory | Sovereign debt management and restructuring, state-owned enterprise strategy | Governments, central banks | Retainers | Details not publicly disclosed |
| Geopolitical Advisory | Integration of geopolitical risk into corporate strategy and transactions; launched 2022 | Multinationals, boards | Retainers | Senior advisors include Lorenzo Bini Smaghi (joined Oct 2026) |
| Defense Technology & Emerging Technology (new group, 2026) | Sector coverage for defense tech and emerging technologies | Defense primes, tech companies, sponsors | Success fees | Head: Matt Spence (joined Sep–Oct 2026) |
| Thought-leadership and research products | Lazard Global Biopharmaceutical Leaders Study (Sep 2026), Interim Secondary Market Report (Aug 2026), Review of Shareholder Activism | Clients and prospects (free) | Marketing tool | — |
Asset Management
| Platform / product line | Description | AUM indicator | Target client | Notes |
|---|---|---|---|---|
| Global / International Equity | Active developed-ex-US and global equity strategies (quality, value, thematic) | Part of the equity total of $214.4 billion at 30 Jun 2026 | Institutions, sub-advisory, intermediaries | Primary driver of H1 2026 net flows (10-Q) |
| Emerging Markets Equity | Long-established EM franchise (core, value, debt-adjacent) | $43.8 billion at 31 Mar 2026 (vs $41.1 billion at Dec-25) | Institutions, SWFs | Flow driver in Q1 2026 |
| US Equity | US large-cap, small-cap and mid-cap strategies | Within equity | Institutions, intermediaries | Drove Q2 2026 net flows |
| Regional / Local Equity | European, Japanese, Australian, UK, French equity (incl. LFG) | Within equity | Regional institutions and private clients | — |
| Fixed Income | Global, EM debt, credit, aggregate | About $34.4 billion at 31 Mar 2026 | Institutions | Monthly release data |
| Multi-Asset (new reporting class, 2026) | Asset allocation and solutions | About $23.1 billion at 31 Mar 2026 | Institutions, wealth | Separately classified from 2026 |
| Alternatives & Private Markets | Hedge-fund-style, private equity, venture (Elaia), late-stage tech growth (Lazard Elaia Capital) | Within the remainder (about $8–9 billion inferred, not disclosed precisely) | Institutions, HNW | Drove H1 2026 flows alongside global equity; Elaia added about $1.0 billion on 30 Jun 2026 |
| Lazard Frères Gestion (France) | French asset and wealth management | — | French private clients and institutions | — |
| Closed-end funds | e.g., Lazard Global Total Return and Income Fund (monthly distributions) | Not material to group | Retail | Monthly distribution notices (Sep 2026) |
| Divested: Edgewater | Interest in Edgewater Funds management vehicles | $1.5 billion at Dec-25; sold 23 Feb 2026 | — | Non-core simplification |
AUM by class is from the Q2 2026 10-Q and monthly releases. The equity sub-strategies below are platforms named in filings.
Product launch years. Fund-level launch years and fee schedules are disclosed in individual prospectuses and were not compiled in this research.
Financial Narrative
Data provenance. FY2021–FY2025 GAAP income statement, balance sheet and cash-flow data are from XBRL-tagged 10-K data (via app.edgar.tools, cross-checked against the FY2025 press release and 10-K MD&A). Revenue for FY2021–FY2022 uses "operating revenue" from the earnings releases. Revenue for FY2023–FY2025 uses "adjusted net revenue."
Income statement
Notes:
-
FY2023 adjusted net revenue of about $2,440 million is the rounded Lazard 2030 baseline. It is consistent with the FY2023 adjusted operating income of $165.6 million at 6.8% margin in the FY2025 ARS.
-
FY2021–FY2022 operating revenue is not GAAP.
-
FY2023 diluted EPS equals basic because of the net loss.
GAAP net revenue (verified years): FY2024 $3,052 million; FY2025 $3,099 million (+2%).
Adjusted (non-GAAP) earnings:
Sources: FY2021, FY2022 and FY2025 earnings releases.
Gross profit / gross margin. Not applicable. As an advisory and asset management firm, Lazard reports no cost of goods sold, and gross profit is not a reported or meaningful metric.
EBITDA. Not reported by Lazard. A proxy is GAAP operating income plus interest expense of $87.3 million (FY2025) and $87.8 million (FY2024), which gives about $415 million and $474 million respectively, before D&A.
Margins and growth
Revenue CAGR:
-
FY2021–FY2025, splicing operating revenue and adjusted net revenue: about −0.9% a year.
-
FY2023–FY2025, adjusted net revenue: about +11.4% a year.
-
Lazard 2030 requires roughly $4.9 billion by 2030 (2× the 2023 base). That implies about 10.4% a year from 2023, or about 10.0% a year from FY2025.
Balance sheet
Notes:
Short-term debt: Lazard reports no short-term senior borrowings. All senior notes are long-term. The 2025 notes were retired by early 2025, and the 2027 notes were redeemed in Q3 2025. At 31 Dec 2025 the nearest maturity is September 2028.
- Historically about $0.4 billion, mostly from legacy acquisitions. This will rise materially on the Campbell Lutyens closing.
Working capital: Not meaningful for a broker-dealer and asset manager, whose balance sheets are unclassified. Not computed.
Interim: Cash was $1.10 billion against senior debt of $1.69 billion at 30 Jun 2026, a seasonal low after the Q1 bonus payout and tax-withholding share settlements (Zacks, citing the 10-Q).
Cash flow
Sources: XBRL cash-flow data.
Capital returned (disclosed):
-
FY2022: $936 million total, including the repurchase of 20 million shares.
-
FY2025: $393 million total.
-
Q1 2026: $174 million, of which $47 million was dividends and $125 million was tax-withholding settlements.
-
July 2026: an additional $200 million buyback authorization.
Ratios
Ratios are derived by the analyst from the tables above.
Not computed (insufficient disclosure in this research, or not meaningful for the business model): ROIC, current ratio (unclassified balance sheet), net debt/EBITDA (EBITDA not reported), and cash conversion cycle (no inventory or payables cycle).
Commentary on trends, inflections and drivers.
-
Cycle shape. FY2021 was a record. FY2022 moderated as M&A cooled and AUM fell 21% to $216 billion. FY2023 was the trough: a GAAP loss, a 6.8% adjusted margin, and restructuring and impairment charges of $19.1 million. FY2024–FY2025 were a recovery to about $3.0 billion of adjusted revenue, though adjusted operating margin plateaued at about 14%, well below the FY2021 level of more than 20%.
-
The margin problem is compensation. The FY2025 adjusted comp ratio was 65.5% against a target of 60% or below. In H1 2026 it rose to 69.9% as Lazard accrued for heavy MD hiring while FA revenue fell 7%. Management guided that the comp ratio should improve in late 2026 if advisory revenue holds, with the larger decline in 2027–2028 as hiring effects fade (Q2 2026 call).
-
GAAP vs adjusted divergence in FY2025. GAAP net income fell 15% to $237 million while adjusted net income rose 9% to $266 million. The gap reflects $50.1 million of senior-management transition expenses and the FY2024 office-building gain of $114 million, which flattered the prior year.
-
ROE is optically high because book equity is small after years of buybacks and share-based-comp mechanics. Leverage of about 1.9× senior debt to equity is moderate in absolute terms; net debt was only $219 million at FY2025.
-
Operating cash flow fell 30% in FY2025, to $519 million, as receivables rose $144 million and tax-withholding settlements nearly doubled. The 2026 dividend run rate of about $200 million (at $2.00 a share on roughly 100 million shares) is covered by normalized OCF. However, the July 2026 buyback combined with the Campbell Lutyens cash component will compress liquidity. That is a point Zacks also raised.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Principal products and services |
|---|---|---|
Financial Advisory (FA) | Global investment banking advisory: Lazard Frères & Co. (US), Lazard Frères SAS (France), Lazard & Co. (UK) and others | M&A and strategic advisory; capital markets and capital solutions advisory; restructuring and liability management (RLM); private capital advisory (PCA); shareholder and activism advisory; sovereign advisory; geopolitical advisory |
Asset Management (AM) | Lazard Asset Management LLC and subsidiaries; Lazard Frères Gestion SAS (France); Lazard Elaia Capital; Elaia Partners (controlled from June 2026) | Active equity (global/international, emerging markets, US, regional); fixed income; multi-asset (a separate AUM class from 2026); alternatives and private markets; closed-end funds; separately managed accounts; French private wealth |
Corporate | Treasury, investments, Lazard Frères Banque-related activities, senior debt, interest, and certain unallocated items | Not a client-facing segment |
Revenue by Segment and Segment Assets & Liabilities
| Segment (GAAP net revenue, USD Mn) | FY2024 | FY2025 |
|---|---|---|
Financial Advisory | 1,756 | 1,834 |
Asset Management | 1,187 | 1,275 |
Corporate and other (derived residual) | 109 | -10 |
Total Lazard net revenue | 3,052 | 3,099 |
Revenue by Segment and Segment Assets & Liabilities — Financial Advisory
| Segment (adjusted net revenue, USD Mn) | FY2024 | FY2025 |
|---|---|---|
Financial Advisory | 1,731 | 1,825 |
Asset Management | 1,100 | 1,166 |
Corporate and other (derived residual) | 59 | 39 |
Total adjusted net revenue | 2,890 | 3,030 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2024 | FY2025 | Source |
|---|---|---|---|
FA adjusted net revenue YoY growth (%) | n/m | 5 | FY2025 release |
AM adjusted net revenue YoY growth (%) | n/m | 6 | FY2025 release |
FA share of adjusted net revenue (%) | 59.9 | 60.2 | Derived |
AM share of adjusted net revenue (%) | 38.1 | 38.5 | Derived |
FA adjusted operating income (USD Mn) | 397 | 441 | FY2025 10-K MD&A |
FA adjusted operating margin (%) | 22.9 | 24.2 | FY2025 10-K MD&A |
Firm adjusted operating income (USD Mn) | 411 | 432 | FY2025 ARS |
Firm adjusted operating margin (%) | 14.2 | 14.3 | FY2025 ARS |
Revenue by Segment
| Segment metric (USD Mn) | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
FA net revenue (GAAP) | 367 | 495 | 360 | 450 |
FA adjusted net revenue | 371 | 489 | 356 | 445 |
AM net revenue (GAAP) | 289 | 292 | 410 | 351 |
AM adjusted net revenue | 264 | 268 | 309 | 331 |
Firm net revenue (GAAP) | 648 | 760 | 757 | 808 |
Firm adjusted net revenue | 643 | 691 | 673 | 786 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue — operating revenue FY21–22, adjusted net revenue FY23–25 (USD Mn) | 3,139 | 2,769 | 2,440 | 2,890 | 3,030 |
Operating income, GAAP, equals pre-tax income (USD Mn) | 724 | 517 | -80 | 386 | 328 |
Provision (benefit) for income taxes (USD Mn) | 181 | 124 | -23 | 100 | 77 |
Net income incl. NCI (USD Mn) | 543 | 392 | -57 | 287 | 251 |
Net income attributable to Lazard (USD Mn) | 528 | 358 | -75 | 280 | 237 |
EPS basic (USD) | 4.90 | 3.68 | -0.90 | 2.93 | 2.37 |
EPS diluted (USD) | 4.63 | 3.51 | -0.90 | 2.68 | 2.17 |
Diluted weighted shares (M) | 114 | 101 | 89 | 102 | 106 |
Income Statement and Per-Share Data — Adjusted net income
| Metric | FY2021 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|
Adjusted net income (USD Mn) | 576 | 384 | 244 | 266 |
Adjusted diluted EPS (USD) | 5.04 | 3.73 | 2.34 | 2.44 |
Margin Analysis (%) and Financial Ratios (x)
| Metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Pre-tax margin on reported revenue row | 23.1 | 18.7 | -3.3 | 13.4 | 10.8 |
Net margin, attributable NI on reported revenue row | 16.8 | 12.9 | -3.1 | 9.7 | 7.8 |
Adjusted operating margin | 0 | 0 | 6.8 | 14.2 | 14.3 |
Adjusted compensation ratio | 0 | 0 | 0 | 65.9 | 65.5 |
Adjusted non-compensation ratio | 0 | 0 | 0 | 19.9 | 20.2 |
Effective tax rate (GAAP) | 25.0 | 24.0 | 28.8 | 25.8 | 23.4 |
Financial Analysis
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 7,147 | 5,853 | 4,636 | 4,794 | 4,941 |
Cash and cash equivalents | 1,465 | 1,235 | 971 | 1,308 | 1,469 |
Restricted cash | 617 | 625 | 34 | 32 | 34 |
Investments | 1,007 | 699 | 702 | 615 | 626 |
Receivables, net | 806 | 653 | 762 | 754 | 898 |
Senior debt (carrying value; all long-term) | 1,685 | 1,688 | 1,690 | 1,687 | 1,688 |
Net debt (senior debt minus cash and equivalents) | 220 | 453 | 719 | 379 | 219 |
Total Lazard stockholders' equity | 975 | 556 | 424 | 636 | 874 |
Total stockholders' equity incl. NCI | 1,078 | 675 | 482 | 685 | 911 |
Financial Analysis — Net cash from operating activities
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net cash from operating activities | 866 | 834 | 165 | 743 | 519 |
Share-based comp settled for tax withholding | 68 | 62 | 55 | 64 | 115 |
Issuance of senior debt | 0 | 0 | 0 | 396 | 300 |
Extinguishment of senior debt | 0 | 0 | 0 | 399 | 298 |
Amortization of deferred expenses and share-based comp | 0 | 406 | 430 | 448 | 460 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, attributable NI on ending Lazard equity (%) | 54.2 | 64.4 | -17.7 | 44.0 | 27.1 |
ROA, attributable NI on ending total assets (%) | 7.4 | 6.1 | -1.6 | 5.8 | 4.8 |
Senior debt / Lazard equity (x) | 1.73 | 3.04 | 3.99 | 2.65 | 1.93 |
Asset turnover, reported revenue row on ending assets (x) | 0.44 | 0.47 | 0.53 | 0.60 | 0.61 |
Interest coverage, (operating income + interest) / interest (x) | 0 | 0 | -0.03 | 5.4 | 4.8 |
Region (Approximate Share of Revenue, %) Overview
| Region (approximate share of revenue, %) | Share |
|---|---|
Americas | 60 |
EMEA | 35 |
Asia-Pacific | 5 |
Capital Markets
| Item | Value | Source |
|---|---|---|
Last close | $36.09 | Benzinga (16 Oct 2026) |
52-week range | $34.13 – $58.75 | Benzinga |
Market capitalization | About $3.52 billion | Benzinga / CNN |
Shares outstanding | About 97.45 million | Google Finance |
Trailing P/E | About 17.8× (on trailing EPS of about $2.04) | Google Finance |
Dividend | $0.50 quarterly ($2.00 annualized); yield about 5.5% | Google Finance; Lazard releases |
Beta | About 1.4 | Motley Fool / Google |
1-year price change | About −34% (in AUD terms per CompaniesMarketCap; USD-basis approximately similar) | Flagged approximate |
Share price at Q1 2026 results | $48.50 previous close, falling to about $44.51 | Investing.com |
Share price at Q2 2026 results | $43.58 previous close, falling to about $41.95 premarket | Investing.com |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends declared per share (USD) | 1.88 | 1.97 | 2.00 | 2.00 | 2.00 |
Credit Ratings
| Agency | Rating (Lazard Group senior unsecured) | Outlook | As of |
|---|---|---|---|
Moody's | Baa3 | Stable | Jul 2025 |
S&P | BBB+ | Stable | Jul 2025 |
Fitch | BBB+ | Stable | Jul 2025 |
Notes (Lazard Group Llc, Guaranteed by Lazard, Inc.) Details
| Notes (Lazard Group LLC, guaranteed by Lazard, Inc.) | Coupon (%) | Maturity | Principal (USD Mn) |
|---|---|---|---|
2028 Senior Notes | 4.50 | 19 Sep 2028 | 500 |
2029 Senior Notes | 4.375 | 11 Mar 2029 | 500 |
2031 Senior Notes | 6.00 | 15 Mar 2031 | 400 |
2035 Senior Notes | 5.625 | 1 Aug 2035 | 300 |
Total | — | — | 1700 |
Analyst Conclusions
Management guidance (latest)
- H2 2026 FA revenue to exceed H1 2026, supported by the pipeline and ramping new MDs (Q2 2026 call). For reference, H1 2026 FA adjusted revenue was $801 million.
Comp ratio: to improve late in 2026 if advisory revenue holds, with the bigger step-down in 2027–2028. The long-term target is 60% or below.
Non-comp ratio: target of 16–20%. 2026 non-comp growth is guided at mid-to-high single digits.
Positive AM net flows for 2026: YTD through June: +$7.4 billion. July–September included a September outflow of $0.9 billion.
Campbell Lutyens: closing expected by calendar year-end 2026; accretive to 2027 EPS.
Lazard 2030: double revenue versus 2023; $12.5 million per MD.
Consensus: Estimates imply 2026 EPS down about 11% YoY and 2027 EPS up about 84% (Zacks). That makes 2027 the "show-me" year.
Bull case
-
The operating-leverage inflection is mechanical. About $3.0 billion of revenue at a 70% comp ratio produces roughly 14% adjusted margins. If revenue grows about 10% a year toward the 2030 target and the comp ratio falls 5 points, adjusted operating income could roughly double by 2028. Management explicitly guides to a 2027–2028 comp-ratio step-down.
-
Lazard CL is a structural re-rating catalyst. About $500 million of 2027 revenue in a secular growth niche, closer to the "annuity" end of advisory, moves private-capital connectivity to about 50%. Placement and secondaries peers such as PJT Park Hill command premium multiples.
-
Asset Management is turning. H1 2026 had the best first-half net inflows in nearly 20 years. Average AUM rose 17% YoY in Q2 and Q3 average AUM reached $286.6 billion, up roughly 11% on Q3 2025's $257.4 billion. Management fees grew 23% YoY in Q2 2026 to $310 million, and that revenue is already in the run rate.
Bear case
-
Advisory share erosion. In the strongest M&A year since 2021, Lazard's FA grew 5% while peers grew 15–29%. FA then fell 7% in H1 2026. The MD hiring wave is so far adding cost (comp ratio up from 65.5% to 69.9%) faster than revenue.
-
Flow durability is unproven. May and September 2026 outflows and the 2025 sub-advisory loss suggest the AM inflection is lumpy. More than 75% of AUM in active equity leaves revenue hostage to markets and FX, as March 2026's loss of more than $20 billion in a single month showed.
-
Execution and governance strain. A new CFO in February 2026, a CAO departure in December 2026, a new LAM CEO in December 2025 and a large cross-border integration all land at once. Two consecutive EPS misses and serial target cuts point to a credibility deficit that the stock may not recover until 2027 numbers are visible.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| 22 Oct 2026 | Q3 2026 results: FA revenue versus the H2-greater-than-H1 guide; comp-ratio trajectory; tax normalization; Q3 AM revenue on $286.6 billion average AUM |
| Nov 2026 – Jan 2027 | Monthly AUM releases (net flows); closing of Campbell Lutyens and launch of Lazard CL; purchase-price allocation and goodwill |
| 11 Dec 2026 | CAO transition becomes effective (watch for any control or filing delays) |
| Late Jan 2027 | FY2026 results; FY2026 comp ratio; MD count and revenue per MD; 2027 framing |
| Q1 2027 | FY2026 10-K: Lazard CL segment presentation; dividend and buyback decisions |
| Spring 2027 | 2027 proxy (implementation of declassification); any Lazard 2030 target refresh |
| Ongoing | Megadeal closings (NextEra/Dominion, SFR) converting to fees; sponsor M&A recovery; USD direction |
Analyst verdict
Lazard enters the final quarter of 2026 as a franchise whose strategic logic is improving while its reported economics are deteriorating, and the market is pricing the latter. Strategically, the firm has done most of what a credible turnaround requires. It converted to a C-corporation, rebuilt the Asset Management leadership around an experienced outsider, exited non-core vehicles such as Edgewater, consolidated control of a private-markets platform in Elaia, and agreed the transformative Campbell Lutyens deal. That deal should give Lazard the leading private-capital advisory platform and lift private-capital connectivity to its 2030 target years early. Asset Management, for years the drag, has delivered its best first-half flows in two decades and record AUM.
Financially, however, the evidence is less encouraging. In 2025, the best M&A year in four years, Lazard's advisory revenue grew a fraction as fast as Evercore, Moelis or PJT. In 2026 it has declined. The aggressive hiring that underpins Lazard 2030 has pushed the adjusted compensation ratio to about 70%, ten points above target. That in turn produced two consecutive large EPS misses and a de-rating to roughly 15× trailing adjusted earnings, near 52-week lows, with a dividend yield of about 5.5%.
Our assessment is that the stock now discounts a good deal of execution risk. The balance sheet is sound: investment-grade, no maturities before 2028, and modest net debt. The dividend appears sustainable. But the thesis hinges on one variable, revenue per MD, and management has asked investors to wait until 2027–2028 for the payoff. Absent evidence in the Q3 and Q4 2026 prints that advisory revenue is re-accelerating and the comp ratio has peaked, upside is likely capped despite the valuation. If H2 2026 advisory revenue clearly exceeds H1 and Lazard CL closes on schedule, the combination of a depressed multiple and operating leverage could drive a sharp re-rating. We would characterize the risk/reward as balanced with a positive skew for patient, catalyst-driven holders, contingent on the next two quarterly reports.
End of dossier. All figures are as reported or derived from Lazard SEC filings and releases through 13 October 2026 unless flagged as third-party. This document is for informational purposes and is not investment advice.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure in role | Prior roles / background | Age |
|---|---|---|---|---|
Peter R. Orszag | CEO (since Oct 2023) and Chairman (since Jan 2025) | CEO about 3 years | CEO of Financial Advisory 2019–2023; joined 2016 from Citigroup (Vice Chairman, CIB); Director of OMB 2009–2010; Director of CBO 2007–2008; Clinton White House economic roles; PhD (LSE), AB (Princeton) | 57 (10-K, Feb 2026) |
Tracy Farr | Chief Financial Officer (from 1 Feb 2026); to add principal accounting officer duties from 11 Dec 2026 | Under 1 year | Lazard MD, Capital Structure Advisory, and senior member of corporate development and strategy; joined 2013; previously CPA and consultant at EY and researcher at FASB; BS and MS in Accounting, Brigham Young University | — |
Alexandra Soto | Global Chief Operating Officer | About 3 years | Leads global client development and the firm's AI-enablement agenda; previously Group Executive, Human Capital and Workplace Innovation (10-K) | — |
Christopher Hogbin | CEO, Lazard Asset Management (since Dec 2025) | Under 1 year | About 20 years at AllianceBernstein (Global Head of Investments, Head of Equities, Executive Leadership Team); earlier Boston Consulting Group | — |
Raymond J. McGuire | President of Lazard; Co-Head of Financial Advisory, North America | President since 2022 | Former Vice Chairman, Citigroup; 2021 NYC mayoral candidate | — |
Christian A. Weideman | General Counsel | About 3 years | Retention agreement April 2025 | — |
Michael Gathy | Chief Accounting Officer (resigning effective 11 Dec 2026) | About 3 years | — | — |
Tim Donahue | Global Head of Capital Solutions; Co-Head of FA North America | Since Dec 2025 (co-head) | — | — |
Holcombe Green | Global Head of Private Capital Advisory; designated Co-CEO of Lazard CL | — | Grew PCA revenue more than 2× over five years | — |
Gordon Bajnai | CEO, Campbell Lutyens; designated Co-CEO of Lazard CL | On closing | Former Prime Minister of Hungary (2009–2010) | — |
Jason Bernhard | COO, Financial Advisory | — | — | — |
Kenneth M. Jacobs | Senior Chairman and Senior Advisor to the Board (non-executive) | Since late 2024 / Jan 2025 | Chairman and CEO 2009–2023; elected Chairman of Vanguard's board (July 2026) | — |
“—” = not publicly disclosed.
Directors' Remuneration
| Executive | Salary (USD) | Bonus (USD) | Stock awards (USD) | All other (USD) | SCT total (USD) | Source |
|---|---|---|---|---|---|---|
Peter Orszag, CEO | 900,000 | 3,900,000 | 8,666,548 | 256,904 | 13,723,452 | 2026 PRE 14A / DEF 14A |
Christopher Hogbin, CEO LAM | — | — | — | — | about 20.91 million (likely includes sign-on and make-whole awards) | Simply Wall St (aggregator, flagged) |
Alexandra Soto, COO | — | — | — | — | about 8.00 million | Simply Wall St (flagged) |
Christian Weideman, GC | — | — | — | — | about 4.35 million | Simply Wall St (flagged) |
Mary Ann Betsch, former CFO | Full 2025 bonus equal to 2024 bonus; Senior Advisor through 30 Jun 2026; no 2026 pro-rata bonus | — | — | — | — | 8-K, 2 Feb 2026 |
Board & Management Changes
| Date | Change |
|---|---|
1 Oct 2023 | Orszag becomes CEO; Jacobs becomes Executive Chairman |
Jan 2025 | Orszag becomes Chairman; Jacobs becomes Senior Chairman |
8 Sep 2025 / Dec 2025 | Hogbin succeeds Russo as CEO of LAM |
Dec 2025 | McGuire and Donahue named co-heads of FA North America; Soto's remit includes AI |
1 Feb 2026 | Farr succeeds Betsch as CFO |
30 Jun 2026 | Betsch separates |
12–13 Oct 2026 | CAO Gathy resigns effective 11 Dec 2026; Farr to absorb the PAO role at no additional pay |
Competitive Landscape
Peer Comparison FY2025
| Metric (FY2025) | Lazard | Evercore | Moelis | PJT Partners |
|---|---|---|---|---|
Revenue, adjusted (USD Mn) | 3,030 | 3,900 | 1,536 | 1,714 |
Revenue growth YoY (%) | 5 | 29 | 28 | 15 |
Adjusted operating / pre-tax margin (%) | 14.3 | 21.6 | 21.5 | 20.8 |
Adjusted comp ratio (%) | 65.5 | 0 | 0 | 67.1 |
R&D intensity (%) | 0 | 0 | 0 | 0 |



